Nemaura Medical Inc.
NMRD
$0.0001
-$0.0001-50.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -25.94% | 68.79% | 33.06% | -29.46% | 49.99% |
| Total Depreciation and Amortization | -16.16% | 77.54% | -0.71% | 94.89% | 65.06% |
| Total Amortization of Deferred Charges | 25.97% | -83.02% | -88.68% | -249.57% | -33.94% |
| Total Other Non-Cash Items | 5.29% | -346.62% | -54.67% | 938.80% | -1,297.04% |
| Change in Net Operating Assets | 1,440.46% | 40.81% | 36.63% | 39.56% | -101.41% |
| Cash from Operations | 3.99% | -47.94% | -5.75% | -9.82% | -75.64% |
| Capital Expenditure | 84.43% | 79.71% | -14.06% | 17.97% | 52.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | 116.88% |
| Cash from Investing | 81.94% | 77.25% | 86.59% | -31.24% | 70.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -76.47% | -71.89% | 24.60% | 61.02% | 37.04% |
| Issuance of Common Stock | -- | -- | -- | 179.78% | -99.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -1,489.22% | 93.18% |
| Cash from Financing | -76.51% | 361.45% | -4,745.22% | 281.78% | 34.27% |
| Foreign Exchange rate Adjustments | -52.94% | 61.50% | 117.15% | -4.94% | 912.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -53.16% | 107.94% | -103.36% | 152.19% | 25.61% |